共查询到20条相似文献,搜索用时 31 毫秒
1.
2.
3.
4.
Mancl ME Hu G Sangster-Guity N Olshalsky SL Hoops K Fitzgerald-Bocarsly P Pitha PM Pinder K Barnes BJ 《The Journal of biological chemistry》2005,280(22):21078-21090
5.
6.
7.
8.
9.
10.
11.
Interferon regulatory factor 3 (IRF-3) plays a crucial role in host defense against viral and microbial infection as well as in cell growth regulation. IRF-3a is the only structurally and functionally characterized IRF-3 splicing variant and has been established to antagonize IRF-3 activity. Here, five novel splicing variants of IRF-3, referred to as IRF-3b, -3c, -3d, -3e, and -3f, were identified and shown to be generated by deletion of exons 2, 3, or 6 or some combination thereof. RT-PCR examination revealed that these novel splicing variants were more frequently expressed in human liver, esophagus, and cervical tumor tissues than in their normal counterparts. Additionally, electrophoretic mobility shift assay and subcellular localization showed only IRF-3 and IRF-3e were capable of binding the PRDI/III element of interferon-beta (IFNβ) promoter in vitro and underwent cytoplasm-to-nucleus translocation following Poly(I:C) stimulation. Coimmunoprecipitation assay revealed that only IRF-3c (3f) of novel splicing variants associated with IRF-3 in vivo. Further luciferase assay showed IRF-3c (3f) and IRF-3e failed to transactivate PRDI/III-containing promoter but appeared to inhibit transactivation potential of IRF-3 to varying degrees. Taken together, our findings suggest novel splicing variants may function as negative modulators of IRF-3 and may be correlated with pathogenesis of human tumors. 相似文献
12.
13.
14.
15.
Crystal structure of IRF-3 in complex with CBP 总被引:1,自引:0,他引:1
Qin BY Liu C Srinath H Lam SS Correia JJ Derynck R Lin K 《Structure (London, England : 1993)》2005,13(9):1269-1277
16.
17.
18.
19.